Treatment of Patients With Atherosclerotic Disease With Methotrexate-associated to LDL Like Nanoparticles

NCT04616872 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerosis
Coronary Artery Disease
Inflammation

Interventions

DRUG: Methotrexate-LDE
DRUG: Placebo-LDE

Sponsor

University of Sao Paulo General Hospital